Increase of German annuity fees for patents from 1 July 2022
GERMAN DESK 🔊 Increase of German annuity fees for patents from 1 July 2022 Germany decided to increase the yearly annuity payments for patents from July this year. In Germany,
Covid-19 RNA vaccines – a patent dispute.
On March 17, Alnylam Pharmaceuticals has filed infringement suits against Pfizer and Moderna. The concept of vaccination dates from the French Louis Pasteur (nineteenth century), where inactivated virus are
Russian-Ukrainian conflict, what impact on IP rights?
While the conflict between Russia and Ukraine continues, many countries have announced economic sanctions as an alternative to imposing military forces. As a major aspect of any economy, IP
Get to know our IP specialists: 4 questions to our Patent Engineer Alexandre Sylvestre
Alex, could you explain us a bit why you have chosen for the new venture at CALYSTA ? I joined Calysta because I was intrigued how young, dynamic and diverse
Get to know our IP specialists: 4 questions to our Senior Patent Attorney Daisy Bayot
Daisy, could you tell us a bit more about your education, background and experience? My technical background is chemistry. I studied at the UCLouvain where I obtained a bachelor’s
The Unified Patent Court for European patent litigation was born today
The Unified Patent Court for European patent litigation was born today The European Union announced today the entry into force of the Protocol on Provisional Application of the Unified Patent
Get to know our IP specialists: 4 questions to our Patent Attorney Eloïse Ramm
Eloïse, could you tell us a bit more about your background and experience? I studied in the South of France (and yes, I’m not a real Belgian). I obtained a
Belgian inventors not slowed down by pandemic
The coronavirus has drastically changed our lives and one might expect this would affect how many inventions are done. Some have not been able to work at all, and for
Get to know our IP specialist: 4 questions to our Patent Attorney, Claude Gérard
Claude, could you tell us a bit more about you? I have always been interested in scientific discoveries. After a bioengineering degree, I did a PhD in computational biology where
Get to know our IP specialist: 4 questions to our Patent Attorney, Sjors de Koning
Sjors, could you explain us a bit why you have chosen for the new venture at CALYSTA ? Since Calysta was founded, I noticed the company quickly became an important